No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas

J Neurol. 2018 Feb;265(2):431-432. doi: 10.1007/s00415-017-8717-3. Epub 2017 Dec 22.

Fabian Trillsch^{1

2}, Peter Eichhorn³, Leticia Oliveira-Ferrer², Tania Kuempfel⁴, Alexander Burges¹, Sven Mahner^{1

2}, Joachim Havla⁵

¹ Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
² Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany.
³ Institute of Laboratory Medicine, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
⁴ Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany.
⁵ Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Marchioninistr 15, 81377, Munich, Germany. Joachim.Havla@med.uni-muenchen.de.

No abstract available

Publication types